Edition:
United Kingdom

YiChang HEC ChangJiang Pharmaceutical Co Ltd (1558.HK)

1558.HK on Hong Kong Stock

32.75HKD
24 Sep 2018
Change (% chg)

HK$-0.45 (-1.36%)
Prev Close
HK$33.20
Open
HK$32.85
Day's High
HK$33.40
Day's Low
HK$31.90
Volume
1,760,400
Avg. Vol
2,524,473
52-wk High
HK$51.60
52-wk Low
HK$19.16

Chart for

About

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceutical products. The Company is also engaged in the research and development, marketing and distribution of pharmaceuticals. The products of the Company include anti-viral drugs, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): HK$8,931.97
Shares Outstanding(Mil.): 452.02
Dividend: 0.47
Yield (%): 3.27

Financials

  1558.HK Industry Sector
P/E (TTM): 16.26 30.93 32.76
EPS (TTM): 1.22 -- --
ROI: 17.78 15.07 14.61
ROE: 18.94 16.59 16.33

Blackstone invests $400 million in HEC Pharm via convertible bonds

HONG KONG U.S. private equity firm Blackstone Group LP has signed a deal to invest $400 million in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co. via convertible bonds, HEC said Wednesday.

15 Aug 2018

Blackstone invests $400 mln in HEC Pharm via convertible bonds

HONG KONG, Aug 15 U.S. private equity firm Blackstone Group LP has signed a deal to invest $400 million in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co. via convertible bonds, HEC said Wednesday.

15 Aug 2018

Earnings vs. Estimates